Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Biomed Sci ; 17: 83, 2010 Nov 05.
Artigo em Inglês | MEDLINE | ID: mdl-21054849

RESUMO

BACKGROUND: To assess the effects of Glycine tomentella Hayata (GTH), a traditional herbal medicine for treatment of rheumatic diseases on the expression of the proinflammatory cytokines and on the clearance of apoptotic cells by macrophages. METHODS: RAW264.7 cells were cultured with lipopolysaccharide (LPS) in the presence or absence of ethanol extract of GTH. The expression of proinflammatory cytokines IL-1ß, IL-6, and TNF-α, and inducible nitric oxide synthase (iNOS) and transglutaminase 2 (TG2) were assayed by reverse transcriptase-polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA). Matrix metalloproteinase (MMP)-2 and MMP-9 were assayed by gelatin zymography. For detecting uptake of apoptotic cells, RAW264.7 cells were cultured with carboxyfluorescein diacetate (CFDA)-stained apoptotic cells and assayed by flow cytometry. RESULTS: The major components of GTH analyzed by high-performance liquid chromatography (HPLC) chromatogram were daidzein (42.5%), epicatechin (28.8%), and naringin (9.4%).GTH treatment inhibited the expression of proinflammatory cytokines IL-1ß, IL-6 and MMP-9 but did not affect the expression of TNF-α and iNOS. GTH significantly enhanced the expression of TG2 and the clearance of apoptotic cells by RAW264.7 macrophages. CONCLUSIONS: GTH inhibits proinflammatory cytokine secretion and MMP-9 activity, enhances apoptotic cell uptake and up-regulates TG2 expression. Our data show that GTH might have beneficial effects on rheumatic diseases.


Assuntos
Apoptose , Glicina , Interleucina-1beta/metabolismo , Interleucina-6/metabolismo , Macrófagos , Inibidores de Metaloproteinases de Matriz , Extratos Vegetais/farmacologia , Animais , Linhagem Celular , Proteínas de Ligação ao GTP/metabolismo , Glicina/química , Glicina/metabolismo , Lipopolissacarídeos/farmacologia , Macrófagos/citologia , Macrófagos/efeitos dos fármacos , Macrófagos/metabolismo , Metaloproteinase 9 da Matriz/metabolismo , Camundongos , Óxido Nítrico Sintase Tipo II/metabolismo , Extratos Vegetais/química , Proteína 2 Glutamina gama-Glutamiltransferase , Transglutaminases/metabolismo , Fator de Necrose Tumoral alfa/metabolismo
2.
Radiat Res ; 166(6): 900-7, 2006 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17149981

RESUMO

Bone marrow and intestinal damage limits the efficacy of radiotherapy for cancer and can result in death if the whole body is exposed to too high a dose, as might be the case in a nuclear accident or terrorist incident. Identification of an effective nontoxic biological radioprotector is therefore a matter of some urgency. In this study, we show that an orally administered hot-water extract from a Chinese herbal medicine, Cordyceps sinensis (CS), protects mice from bone marrow and intestinal injuries after total-body irradiation (TBI). CS increased the median time to death from 13 to 20 days after 8 Gy TBI and from 9 to 18 days after 10 Gy TBI. Although CS-treated mice receiving 10 Gy TBI survived intestinal injury, most died from bone marrow failure, as shown by severe marrow hypoplasia in mice dying between 18 and 24 days. At lower TBI doses of 5.5 and 6.5 Gy, CS protected against bone marrow death, an effect that was confirmed by the finding that white blood cell counts recovered more rapidly. In vitro, CS reduced the levels of free radical species (ROS) within cells, and this is one likely mechanism for the radioprotective effects of CS, although probably not the only one.


Assuntos
Doenças da Medula Óssea/prevenção & controle , Cordyceps/química , Medicamentos de Ervas Chinesas/administração & dosagem , Enteropatias/prevenção & controle , Lesões por Radiação/patologia , Lesões por Radiação/prevenção & controle , Tolerância a Radiação/efeitos dos fármacos , Animais , Doenças da Medula Óssea/etiologia , Doenças da Medula Óssea/patologia , Enteropatias/etiologia , Enteropatias/patologia , Camundongos , Camundongos Endogâmicos C57BL , Proteção Radiológica/métodos , Taxa de Sobrevida
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA